Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today, on the 80-year anniversary of the Nobel Prize being awarded for the discovery and development of penicillin, Dr Alistair Farley, Scientific Lead at the Ineos Oxford Institute for antimicrobial research (IOI), urges that the collaboration behind this achievement is channelled again today to address one of the greatest global medical challenges of our time.

Packages of pills of different colours and shapes © sprng23, Getty Images

On 10 December 1945, Alexander Fleming, Howard Florey, and Ernst Chain were jointly awarded the Nobel Prize in Physiology or Medicine ‘for the discovery of penicillin and its curative effect in various infectious diseases.’ The discovery of penicillin and its subsequent industrial production during World War Two is rightly hailed as one of the biggest medical breakthroughs of the 20th century. Penicillin played a pivotal role for millions of allied soldiers and over the last 80 years has saved hundreds of millions of lives.

The development of penicillin established a new model for translational research. Fleming’s discovery of penicillin from the Penicilium mould was published as a curious observation. Building on these findings, Florey, Chain and Norman Heatley at the Dunn School of Pathology in Oxford isolated penicillin for the first time, with bedpans being used to grow and ferment the mould. Although quantities of pure penicillin were limited, they were sufficient to demonstrate its curative effects in mice and a human patient. The penicillin program was subsequently supported by a grant by the Rockefeller foundation, then by involvement of British and US pharmaceutical companies, backed by their governments. This led remarkably quickly to mass production of penicillin, in an early example of transatlantic collaboration for biomedical research.

 

Read the full story on the University of Oxford website.

 

 

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience